ID   ML-1 [Human leukemia]
AC   CVCL_0436
SY   ML1
DR   BTO; BTO:0001884
DR   CLO; CLO_0007735
DR   MCCL; MCC:0000331
DR   CLDB; cl3489
DR   Cell_Model_Passport; SIDM00440
DR   Cosmic; 787453
DR   Cosmic; 798669
DR   Cosmic; 919125
DR   Cosmic; 924048
DR   Cosmic; 947369
DR   Cosmic; 994171
DR   Cosmic; 998746
DR   Cosmic; 999727
DR   Cosmic; 1037658
DR   Cosmic; 1078735
DR   Cosmic; 1078738
DR   Cosmic; 1127255
DR   Cosmic; 2089662
DR   Cosmic; 2301563
DR   ECACC; 88113007
DR   Wikidata; Q54905840
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1571549;
RX   PubMed=3458526;
RX   PubMed=6091813;
RX   PubMed=7798274;
RX   PubMed=8814454;
RX   PubMed=9510473;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=21552520;
RX   PubMed=23955599;
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Omics: Deep quantitative phosphoproteome analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG; ECACC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 14,18
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 16,17
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 8,13
ST   FGA: 23,25
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1418 ! ML-2
OI   CVCL_H526 ! ML-3
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 21
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=1571549; DOI=10.1182/blood.V79.9.2378.2378;
RA   Sugimoto K., Toyoshima H., Sakai R., Miyagawa K., Hagiwara K.,
RA   Ishikawa F., Takaku F., Yazaki Y., Hirai H.;
RT   "Frequent mutations in the p53 gene in human myeloid leukemia cell
RT   lines.";
RL   Blood 79:2378-2383(1992).
//
RX   PubMed=3458526;
RA   Ohyashiki K., Ohyashiki J.H., Sandberg A.A.;
RT   "Cytogenetic characterization of putative human myeloblastic leukemia
RT   cell lines (ML-1, -2, and -3): origin of the cells.";
RL   Cancer Res. 46:3642-3647(1986).
//
RX   PubMed=6091813; DOI=10.1182/blood.V64.5.1059.1059;
RA   Palumbo A., Minowada J., Erikson J., Croce C.M., Rovera G.;
RT   "Lineage infidelity of a human myelogenous leukemia cell line.";
RL   Blood 64:1059-1063(1984).
//
RX   PubMed=7798274; DOI=10.1016/S0021-9258(18)31687-9;
RA   Carrier F., Smith M.L., Bae I., Kilpatrick K.E., Lansing T.J.,
RA   Chen C.-Y., Engelstein M., Friend S.H., Henner W.D., Gilmer T.M.,
RA   Kastan M.B., Fornace A.J. Jr.;
RT   "Characterization of human Gadd45, a p53-regulated protein.";
RL   J. Biol. Chem. 269:32672-32677(1994).
//
RX   PubMed=8814454; DOI=10.1002/(SICI)1098-2264(199607)16:3<204::AID-GCC8>3.0.CO;2-2;
RA   Strout M.P., Mrozek K., Heinonen K., Sait S.N.J., Shows T.B.,
RA   Aplan P.D.;
RT   "ML-1 cell line lacks a germline MLL locus.";
RL   Genes Chromosomes Cancer 16:204-210(1996).
//
RX   PubMed=9510473; DOI=10.1111/j.1349-7006.1998.tb00476.x;
RA   Hosoya N., Hangaishi A., Ogawa S., Miyagawa K., Mitani K., Yazaki Y.,
RA   Hirai H.;
RT   "Frameshift mutations of the hMSH6 gene in human leukemia cell
RT   lines.";
RL   Jpn. J. Cancer Res. 89:33-39(1998).
//
RX   PubMed=10739008; DOI=10.1016/S0145-2126(99)00182-4;
RA   Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.;
RT   "Frequent microsatellite instability and BAX mutations in T cell acute
RT   lymphoblastic leukemia cell lines.";
RL   Leuk. Res. 24:255-262(2000).
//
RX   PubMed=11226526; DOI=10.1016/S0145-2126(00)00121-1;
RA   Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.;
RT   "Corrigendum to: Frequent microsatellite instability and BAX mutations
RT   in T cell acute lymphoblastic leukemia cell lines Leukemia Research 24
RT   (2000),255-262.";
RL   Leuk. Res. 25:275-278(2001).
//
RX   PubMed=21552520; DOI=10.1371/journal.pone.0019169;
RA   Gu T.-L., Nardone J., Wang Y., Loriaux M., Villen J., Beausoleil S.A.,
RA   Tucker M., Kornhauser J.M., Ren J.-M., MacNeill J., Gygi S.P.,
RA   Druker B.J., Heinrich M.C., Rush J., Polakiewicz R.D.;
RT   "Survey of activated FLT3 signaling in leukemia.";
RL   PLoS ONE 6:E19169-E19169(2011).
//
RX   PubMed=23955599; DOI=10.1038/ng.2731;
RA   Kon A., Shih L.-Y., Minamino M., Sanada M., Shiraishi Y., Nagata Y.,
RA   Yoshida K.-i., Okuno Y., Bando M., Nakato R., Ishikawa S.,
RA   Sato-Otsubo A., Nagae G., Nishimoto A., Haferlach C., Nowak D.,
RA   Sato Y., Alpermann T., Nagasaki M., Shimamura T., Tanaka H., Chiba K.,
RA   Yamamoto R., Yamaguchi T., Otsu M., Obara N., Sakata-Yanagimoto M.,
RA   Nakamaki T., Ishiyama K., Nolte F., Hofmann W.-K., Miyawaki S.,
RA   Chiba S., Mori H., Nakauchi H., Koeffler H.P., Aburatani H.,
RA   Haferlach T., Shirahige K., Miyano S., Ogawa S.;
RT   "Recurrent mutations in multiple components of the cohesin complex in
RT   myeloid neoplasms.";
RL   Nat. Genet. 45:1232-1237(2013).
//